BridgeBio Pharma Sells Rare Pediatric Disease Priority Review Voucher for $110 Million and Defers Principal Payment on Senior Debt by Two Years
–Entered into a definitive agreement to sell the rare pediatric disease Priority Review Voucher (PRV)…
–Entered into a definitive agreement to sell the rare pediatric disease Priority Review Voucher (PRV)…
TORONTO, May 13, 2022 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
PURCHASE, N.Y., May 13, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage neuroscience…
Disposition of MPS programs to reduce operating expenses and extend projected cash runway into 2Q 2023…
MIRAMAR, Fla., May 13, 2022 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW…
DUBLIN, Ireland, May 13, 2022 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical…
BOSTON, May 13, 2022 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company…
-General Alignment with FDA on Key Aspects of Design of Proposed Additional Clinical Trial-Â -Cash Runway…
TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 13, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX:…
— Human Acellular Vessels™ (HAVs™) shipped to six hospitals in Ukraine for treatment of civilian…
TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 13, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (TSX:…
Tauriga Sciences, Inc. Top 3 Finishers – FindThisBest Kosher Chewing Gum Review NEW YORK, NY,…
Conference call begins at 11:00 a.m. Eastern time today WOBURN, Mass., May 13, 2022 (GLOBE…
BUILDING A SOLID BASE OF VAZALORE® USERS Total Net Sales of $2.1 Million in the…
Jishou, Hunan, China–(Newsfile Corp. – May 13, 2022) – The Chinese national intangible cultural heritage…
Investor Call Today at 11am ET Wilmington, Delaware–(Newsfile Corp. – May 13, 2022) – Acorn…
TOKYO, May 13, 2022 – (JCN Newswire) – Lexus globally announces the new UX 200/250h….
KUALA LUMPUR, May 13, 2022 – (ACN Newswire) – CNERGENZ Berhad (CNERGENZ) is pleased to…
DBRS Morningstar notes strong financials, an effective brand, and prudent capital positioning TOPEKA, Kan.–(BUSINESS WIRE)–Security…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule…